These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 16997568

  • 1. The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH.
    Paylor B, Holt S, Fowler CJ.
    Pharmacol Res; 2006 Dec; 54(6):481-5. PubMed ID: 16997568
    [Abstract] [Full Text] [Related]

  • 2. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.
    Clapper JR, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    Pharmacol Res; 2006 Nov; 54(5):341-4. PubMed ID: 16935521
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 4. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S, Paylor B, Boldrup L, Alajakku K, Vandevoorde S, Sundström A, Cocco MT, Onnis V, Fowler CJ.
    Eur J Pharmacol; 2007 Jun 22; 565(1-3):26-36. PubMed ID: 17397826
    [Abstract] [Full Text] [Related]

  • 6. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
    Niforatos W, Zhang XF, Lake MR, Walter KA, Neelands T, Holzman TF, Scott VE, Faltynek CR, Moreland RB, Chen J.
    Mol Pharmacol; 2007 May 22; 71(5):1209-16. PubMed ID: 17314320
    [Abstract] [Full Text] [Related]

  • 7. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
    Zhang D, Saraf A, Kolasa T, Bhatia P, Zheng GZ, Patel M, Lannoye GS, Richardson P, Stewart A, Rogers JC, Brioni JD, Surowy CS.
    Neuropharmacology; 2007 Mar 22; 52(4):1095-105. PubMed ID: 17217969
    [Abstract] [Full Text] [Related]

  • 8. The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.
    Thors L, Alajakku K, Fowler CJ.
    Br J Pharmacol; 2007 Apr 22; 150(7):951-60. PubMed ID: 17325653
    [Abstract] [Full Text] [Related]

  • 9. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
    Naidu PS, Booker L, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Apr 22; 329(1):48-56. PubMed ID: 19118134
    [Abstract] [Full Text] [Related]

  • 10. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
    Hasanein P, Shahidi S, Komaki A, Mirazi N.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):132-5. PubMed ID: 18593578
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats.
    Hlavacova N, Chmelova M, Danevova V, Csanova A, Jezova D.
    Endocr Regul; 2015 Jul 04; 49(3):131-6. PubMed ID: 26238495
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
    Murillo-Rodríguez E, Vázquez E, Millán-Aldaco D, Palomero-Rivero M, Drucker-Colin R.
    Eur J Pharmacol; 2007 May 07; 562(1-2):82-91. PubMed ID: 17336288
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.
    Thors L, Eriksson J, Fowler CJ.
    Br J Pharmacol; 2007 Nov 07; 152(5):744-50. PubMed ID: 17676056
    [Abstract] [Full Text] [Related]

  • 17. Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.
    Holt S, Comelli F, Costa B, Fowler CJ.
    Br J Pharmacol; 2005 Oct 07; 146(3):467-76. PubMed ID: 16100529
    [Abstract] [Full Text] [Related]

  • 18. Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen.
    Holt S, Nilsson J, Omeir R, Tiger G, Fowler CJ.
    Br J Pharmacol; 2001 Jun 07; 133(4):513-20. PubMed ID: 11399668
    [Abstract] [Full Text] [Related]

  • 19. Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance.
    McCallum AL, Limebeer CL, Parker LA.
    Pharmacol Biochem Behav; 2010 Oct 07; 96(4):496-500. PubMed ID: 20643159
    [Abstract] [Full Text] [Related]

  • 20. Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats.
    Manduca A, Servadio M, Campolongo P, Palmery M, Trabace L, Vanderschuren LJ, Cuomo V, Trezza V.
    Eur Neuropsychopharmacol; 2014 Aug 07; 24(8):1337-48. PubMed ID: 24933531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.